Kichul Ko to Lupus Nephritis
This is a "connection" page, showing publications Kichul Ko has written about Lupus Nephritis.
Connection Strength
1.997
-
Cellular aspects of the pathogenesis of lupus nephritis. Curr Opin Rheumatol. 2021 03 01; 33(2):197-204.
Score: 0.735
-
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation. Arthritis Rheumatol. 2016 11; 68(11):2740-2751.
Score: 0.544
-
Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial. Lancet Rheumatol. 2024 Mar; 6(3):e168-e177.
Score: 0.225
-
Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis. J Clin Invest. 2022 07 01; 132(13).
Score: 0.202
-
Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis. Lupus. 2020 May; 29(6):569-577.
Score: 0.172
-
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol. 2014 Dec; 66(12):3359-70.
Score: 0.119